Zhitong Finance App News, Touyun Biotech (01332.HK) issued an announcement. All conditions set out in the subscription agreement have been met, and the completion was implemented on September 7, 2026. A total of 123 million subscribed shares (accounting for 4.38% of the company's issued shares immediately prior to completion and approximately 4.20% of the total number of shares issued by the company after the issuance and issuance of subscription shares) have been successfully allocated and issued to the subscribers at the subscription price of HK$0.122 per subscription share. The total proceeds raised from the self-subscription process were HK$15.06 million, while the net proceeds were approximately HK$14.99 million. It is expected that the full amount will be spent on or before 31 December 2026.

Zhitong Finance App News, Touyun Biotech (01332.HK) issued an announcement. All conditions set out in the subscription agreement have been met, and the completion was implemented on September 7, 2026. A total of 123 million subscribed shares (accounting for 4.38% of the company's issued shares immediately prior to completion and approximately 4.20% of the total number of shares issued by the company after the issuance and issuance of subscription shares) have been successfully allocated and issued to the subscribers at the subscription price of HK$0.122 per subscription share. The total proceeds raised from the self-subscription process were HK$15.06 million, while the net proceeds were approximately HK$14.99 million. It is expected that the full amount will be spent on or before 31 December 2026.